Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
GEVA > SEC Filings for GEVA > Form 8-K on 30-Jun-2014All Recent SEC Filings

Show all filings for SYNAGEVA BIOPHARMA CORP

Form 8-K for SYNAGEVA BIOPHARMA CORP


30-Jun-2014

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On June 30, 2014, Synageva BioPharma Corp. issued a press release announcing top-line results from its global Phase 3 clinical trial of sebelipase alfa in children and adults with lysosomal acid lipase deficiency. The full text of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Press Release issued by Synageva BioPharma Corp. on June 30, 2014


  Add GEVA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for GEVA - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.